Jon Masters
About Jon Masters
Jon Masters is the Executive Director and UC Indication Lead at Bristol Myers Squibb, with over a decade of experience in marketing roles within the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Jon Masters holds the position of Executive Director, UC Indication Lead at Bristol Myers Squibb. In this capacity, he is responsible for leading and managing the strategies and operations related to UC indications. His role includes overseeing marketing initiatives and ensuring alignment with overall business goals within the pharmaceutical landscape.
Early Career Experience
Jon Masters began his career in the pharmaceutical industry at Simpson Healthcare Executives as a Marketing Associate in 2008. He then moved to SGW: Integrated Marketing Communications where he served as a Market Research and Branding Analyst from 2007 to 2008. These roles provided him with foundational experience in market research and branding, critical areas that informed his future career in pharmaceutical marketing.
Professional Journey at LEO Pharma
Jon Masters spent a significant part of his early career at LEO Pharma, fulfilling various roles that broadened his expertise in both marketing and sales. He started as a Marketing Coordinator from 2010 to 2011, transitioned to Associate Product Manager from 2011 to 2012, and then became a Specialty Sales Representative from 2012 to 2013. These experiences offered him a comprehensive view of the pharmaceutical market.
Educational Background
Jon Masters pursued his higher education at Quinnipiac University, where he earned a BS in Marketing from 2004 to 2008 and later an MBA with concentrations in Marketing and Management from 2008 to 2009. This academic foundation played a crucial role in shaping his marketing acumen and management skills, enabling him to excel in his professional endeavors.
Roles at Celgene
Jon Masters transitioned from LEO Pharma to Celgene, where he took on various leadership roles. He was Senior Product Manager, Rheumatology Marketing from 2014 to 2016, Associate Director, Dermatology Marketing from 2016 to 2017, Director, Rheumatology Marketing from 2017 to 2019, Director, Neurology Marketing in 2019, and finally, Senior Director, Neurology Marketing from 2019 to 2020. His tenure at Celgene allowed him to navigate diverse therapeutic areas, from dermatology to neurology and rheumatology.